Figma investors cheer 40% growth, ties to Anthropic and OpenAI—but concerns remain about letting the 'fox into the hen house'

Figma reported Q4 revenue of $303.8 million, up 40% year-over-year (accelerating from 38% in Q3) and finished 2025 with roughly $1.1 billion in annual revenue; net dollar retention was 136% and the company delivered its best-ever net new revenue, sending the stock up ~15% in after-hours trading. However, profitability metrics weakened as adjusted free cash flow margin fell to 13% in Q4 (from 41% in Q1) and gross margin slipped to 86% due to AI inference and infrastructure investments plus a one-time $25 million IP transfer tax tied to the $200 million Weavy acquisition; management plans a March rollout of consumption-based per-seat AI pricing and points to high AI usage among large customers as the path to monetization.

Analysis

Market structure: Figma (FIG) is a clear near-term beneficiary of the AI-design flywheel—136% net dollar retention and +40% revenue YoY with 67 customers >$1M ARR (+68% YoY) imply strong enterprise pricing power and realistic upside to ARPA if consumption pricing converts active AI usage into billable revenue. Losers are legacy SaaS and capex-heavy cloud operators where rising AI inference costs compress FCF (MSFT, AMZN, CRM, ORCL): expect near-term margin pressure and multiple compression if capex persists.

Competitive dynamics: Consumption-based pricing is a structural lever—if March billing converts the 75% heavy-usage cohort into paid consumption, Figma can expand gross monetization and defend share versus incumbents by locking design-code workflows. However, dependency on Anthropic/OpenAI and cloud/GPU supply means margin expansion is conditional, not guaranteed.

Risk assessment: Tail risks include AI lab partners becoming distribution competitors or IP/data regulation (privacy/IP transfer tax headlines are real). Time horizons: immediate (days) — stock volatility around earnings/after-hours; short-term (weeks–months) — first consumption billing read and March usage metrics; long-term (quarters–years) — enterprise footprint and gross margin normalization as infra optimizations scale.

Trade catalysts & hidden dependencies: Key triggers are (1) March consumption billing conversion rates (threshold: >10% uplift in ARPA among $100k+ customers within 90 days), (2) stabilization of adjusted FCF margin >18% over two consecutive quarters, and (3) any change in GPU/cloud pricing or deeper integrations with Anthropic/OpenAI that alter competitive moats.

Key Decisions for Investors

• Establish a tactical long in FIG equal to 1.5–2.5% of portfolio notional: enter equity or buy 9–12 month LEAP calls (e.g., 12-month call strike ~ spot) to capture re-rating if March consumption billing converts. Set hard stop-loss at -25% and target +50–80% over 12 months; trim if adjusted FCF margin fails to exceed 18% in two consecutive quarters.
• Implement a relative-value pair: long FIG 2% vs short CRM 1% (or ORCL 1%) using small notional shorts or buy puts to express the view that FIG’s NDR and enterprise wins will outpace capex-pressured incumbents over 3–9 months. Close if FIG weekly AI usage drops below 50% for two consecutive months or CRM’s ARR growth re-accelerates above 8% QoQ.
• Buy a tactical call spread on FIG expiring June–Sept 2026 (buy ITM/ATM call, sell higher strike to fund) sized to 0.5–1% notional to play consumption-billing upside while capping premium. Exit after first public monthly billing update showing >10% incremental revenue from consumption or by expiry.
• Trim 1–2% exposure to ad/capex-sensitive large caps (META, AMZN, MSFT) and reallocate into AI compute suppliers (e.g., NVDA 1–2%) and select SaaS names with >120% NDR. Rationale: redistribute capital from companies where FCF is being crushed by capex toward firms monetizing AI demand or supplying infra; revisit after next-quarter earnings.